Our blog includes news from LINQ, information about recent events in the projects we work with, and insights into the markets and funding programmes relevant to our projects.
Annual meeting brings WORMVACS2.0 partners to Berlin
On 28 and 29 October, WORMVACS2.0 partners met in Berlin for an annual meeting. With most partners from four continents joining in person and a few online, the hybrid meeting was full of lively, forward-looking discussions on the next steps in building knowledge on helminth vaccine development.
New project: PROTECT builds capacity for maternal vaccine trials
We’re happy to announce the launch of PROTECT, a new EU-funded initiative that aims to strengthen maternal vaccine trial capacity in Kenya, Malawi, Mozambique, and Uganda.
One year into the project, the GenPath Africa consortium came together at the Biomedical Research Institute (BMRI) in Cape Town, South Africa, for its first in-person meeting on May 27-28, 2024.
We are currently looking for a Content and Communications Manager to join the LINQ family. Help us create visibility for our projects and the dedicated people behind them!
New EU project to tackle parasitic worm infections
On 24 and 25 October 2023 the WORMVACs2.0 consortium kicked-off a new 5-year EU-funded project that aims to develop vaccines against schistosome and hookworm infections.
From 02 - 04 October the TB-CAPT consortium convened for a face-to-face progress meeting in Dar-es-Salaam, Tanzania, hosted by our local project partners from Ifakara Health Institute.
Next-generation vaccines against GI mucosal pathogens
Our new project Vax2Muc sets out to develop improved, innovative, next generation subunit vaccines against diseases caused by AMR mucosal pathogens that colonise the GI tract.
